158 related articles for article (PubMed ID: 37434119)
21. Real-World Axitinib Use in the United States: A Retrospective Study Using Linked Datasets.
MacLean E; Cisar L; Mehle K; Eremina D; Quigley JM
J Manag Care Spec Pharm; 2016 Jun; 22(6):723-732u. PubMed ID: 27231799
[TBL] [Abstract][Full Text] [Related]
22. Predicting Renal Cancer Recurrence: Defining Limitations of Existing Prognostic Models With Prospective Trial-Based Validation.
Correa AF; Jegede O; Haas NB; Flaherty KT; Pins MR; Messing EM; Manola J; Wood CG; Kane CJ; Jewett MAS; Dutcher JP; DiPaola RS; Carducci MA; Uzzo RG
J Clin Oncol; 2019 Aug; 37(23):2062-2071. PubMed ID: 31216227
[TBL] [Abstract][Full Text] [Related]
23. Development of a disease-specific health-related quality of life (HRQoL) questionnaire intended to be used in conjunction with the general European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) in renal cell carcinoma patients.
Beisland E; Aarstad HJ; Aarstad AK; Bakke A; Bostad L; Beisland C
Acta Oncol; 2016; 55(3):349-56. PubMed ID: 26251300
[TBL] [Abstract][Full Text] [Related]
24. Prospective bladder cancer infrastructure for experimental and observational research on bladder cancer: study protocol for the 'trials within cohorts' study ProBCI.
Richters A; Meijer RP; Mehra N; Boormans JL; van der Heijden AG; van der Heijden MS; Kiemeney LA; Aben KK
BMJ Open; 2021 May; 11(5):e047256. PubMed ID: 34006553
[TBL] [Abstract][Full Text] [Related]
25. A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry Experience.
Costello BA; Bhavsar NA; Zakharia Y; Pal SK; Vaishampayan U; Jim H; Fishman MN; Molina AM; Kyriakopoulos CE; Tsao CK; Appleman LJ; Gartrell BA; Hussain A; Stadler WM; Agarwal N; Pachynski RK; Hutson TE; Hammers HJ; Ryan CW; Mardekian J; Borham A; George DJ; Harrison MR
Clin Genitourin Cancer; 2022 Feb; 20(1):1-10. PubMed ID: 34364796
[TBL] [Abstract][Full Text] [Related]
26. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic approaches in clear cell and non-clear cell renal cell carcinoma.
Vermassen T; De Meulenaere A; Van de Walle M; Rottey S
Acta Clin Belg; 2017 Feb; 72(1):12-18. PubMed ID: 27356035
[TBL] [Abstract][Full Text] [Related]
28. Etiologic heterogeneity of clear-cell and papillary renal cell carcinoma in the Netherlands Cohort Study.
van de Pol JAA; George L; van den Brandt PA; Baldewijns MMLL; Schouten LJ
Int J Cancer; 2021 Jan; 148(1):67-76. PubMed ID: 32638386
[TBL] [Abstract][Full Text] [Related]
29. The Trial within Cohorts (TwiCs) study design in oncology: experience and methodological reflections.
Kessels R; May AM; Koopman M; Roes KCB
BMC Med Res Methodol; 2023 May; 23(1):117. PubMed ID: 37179306
[TBL] [Abstract][Full Text] [Related]
30. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
31. The association of healthy lifestyle index score and the risk of renal cell cancer in the Netherlands cohort study.
Meer R; van de Pol J; van den Brandt PA; Schouten LJ
BMC Cancer; 2023 Feb; 23(1):156. PubMed ID: 36797692
[TBL] [Abstract][Full Text] [Related]
32. CaboPoint: a phase II study of cabozantinib as second-line treatment in patients with metastatic renal cell carcinoma.
Albiges L; Schmidinger M; Taguieva-Pioger N; Perol D; Grünwald V; Guemas E
Future Oncol; 2022 Mar; 18(8):915-926. PubMed ID: 34911359
[TBL] [Abstract][Full Text] [Related]
33. Long-term Use of Statins and Risk of Renal Cell Carcinoma: A Population-based Case-Control Study.
Pottegård A; Clark P; Friis S; Hallas J; Lund L
Eur Urol; 2016 May; 69(5):877-82. PubMed ID: 26603781
[TBL] [Abstract][Full Text] [Related]
34. Assessing the effect of hyperbaric oxygen therapy in breast cancer patients with late radiation toxicity (HONEY trial): a trial protocol using a trial within a cohort design.
Batenburg MCT; van den Bongard HJGD; Kleynen CE; Maarse W; Witkamp A; Ernst M; Doeksen A; van Dalen T; Sier M; Schoenmaeckers EJP; Baas IO; Verkooijen HM
Trials; 2020 Nov; 21(1):980. PubMed ID: 33246494
[TBL] [Abstract][Full Text] [Related]
35. Reproductive and external hormonal factors and the risk of renal cell cancer in the Netherlands Cohort Study.
Schouten LJ; van de Pol J; Kviatkovsky MJ; van den Brandt PA
Cancer Epidemiol; 2022 Aug; 79():102171. PubMed ID: 35533551
[TBL] [Abstract][Full Text] [Related]
36. Vegetable and fruit consumption and risk of renal cell carcinoma: results from the Netherlands cohort study.
van Dijk BA; Schouten LJ; Kiemeney LA; Goldbohm RA; van den Brandt PA
Int J Cancer; 2005 Nov; 117(4):648-54. PubMed ID: 15929109
[TBL] [Abstract][Full Text] [Related]
37. Relation of height, body mass, energy intake, and physical activity to risk of renal cell carcinoma: results from the Netherlands Cohort Study.
van Dijk BA; Schouten LJ; Kiemeney LA; Goldbohm RA; van den Brandt PA
Am J Epidemiol; 2004 Dec; 160(12):1159-67. PubMed ID: 15583368
[TBL] [Abstract][Full Text] [Related]
38. Real-world Data of Nivolumab for Patients With Advanced Renal Cell Carcinoma in the Netherlands: An Analysis of Toxicity, Efficacy, and Predictive Markers.
Verhaart SL; Abu-Ghanem Y; Mulder SF; Oosting S; Van Der Veldt A; Osanto S; Aarts MJB; Houtsma D; Peters FPJ; Groenewegen G; Van Herpen CML; Pronk LM; Tascilar M; Hamberg P; Los M; Vreugdenhil G; Polee M; Ten Tije AJ; Haanen JBAG; Bex A; van den Eertwegh AJ
Clin Genitourin Cancer; 2021 Jun; 19(3):274.e1-274.e16. PubMed ID: 33317946
[TBL] [Abstract][Full Text] [Related]
39. Protocol for a feasibility study of a cohort embedded randomised controlled trial comparing
Neves JB; Cullen D; Grant L; Walkden M; Bandula S; Patki P; Barod R; Mumtaz F; Aitchison M; Pizzo E; Ranieri V; Williams N; Wildgoose W; Gurusamy K; Emberton M; Bex A; Tran MGB
BMJ Open; 2019 Jun; 9(6):e030965. PubMed ID: 31189686
[TBL] [Abstract][Full Text] [Related]
40. Stereotactic Body radiotherapy and pedicLE screw fixatioN During one hospital visit for patients with symptomatic unstable spinal metastases: a randomized trial (BLEND RCT) using the Trials within Cohorts (TwiCs) design.
Huele EH; van der Velden JM; Kasperts N; Eppinga WSC; Grutters JPC; Suelmann BBM; Weening AA; Delawi D; Teunissen SCCM; Verkooijen HM; Verlaan JJ; Gal R
Trials; 2023 May; 24(1):307. PubMed ID: 37143158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
